Extensive clinical experience - Nonclassical 21-hydroxylase deficiency

被引:208
|
作者
New, Maria I.
机构
[1] CUNY Mt Sinai Sch Med, Adrenal Steroid Disorders Program, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
来源
关键词
D O I
10.1210/jc.2006-1645
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Nonclassical congenital adrenal hyperplasia (CAH) owing to steroid 21-hydroxylase deficiency (NC21OHD) is the most frequent of all autosomal recessive genetic diseases, occurring in one in 100 persons in the heterogeneous New York City population. NC21OHD occurs with increased frequency in certain ethnic groups, such as Ashkenazi Jews, in whom one in 27 express the disease. NC21OHD is underdiagnosed in both male and female patients with hyperandrogenic symptoms because hormonal abnormalities in NC21OHD are only mild to moderate, not severe as in the classical form of CAH. Unlike classical CAH, NC21OHD is not associated with ambiguous genitalia of the newborn female. Main Outcome Measures: The hyperandrogenic symptoms include advanced bone age, early pubic hair, precocious puberty, tall stature, and early arrest of growth in children; infertility, cystic acne, and short stature in both adult males and females; hirsutism, frontal balding, polycystic ovaries, and irregular menstrual periods in females; and testicular adrenal rest tissue in males. Conclusions: The signs and symptoms of hyperandrogenism are reversed with dexamethasone treatment.
引用
收藏
页码:4205 / 4214
页数:10
相关论文
共 50 条
  • [31] 21-hydroxylase deficiency in Brazil
    Bachega, TASS
    Billerbeck, AEC
    Madureira, G
    Marcondes, JAM
    Longui, CA
    Leite, MV
    Arnhold, IJP
    Mendonça, BB
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (10) : 1211 - 1216
  • [32] HLA AND 21-HYDROXYLASE DEFICIENCY
    HARRIS, R
    KLOUDA, PT
    PRICE, DA
    HEREDITY, 1978, 41 (DEC) : 424 - 424
  • [33] GENETICS OF 21-HYDROXYLASE DEFICIENCY
    BOUE, A
    ARCHIVES FRANCAISES DE PEDIATRIE, 1987, 44 (02): : 75 - 78
  • [34] THE GENETICS OF 21-HYDROXYLASE DEFICIENCY
    AISENBERG, JE
    SPEISER, PW
    ENDOCRINOLOGIST, 1994, 4 (02): : 92 - 98
  • [35] Nonclassic 21-hydroxylase deficiency
    Dewailly, D
    SEMINARS IN REPRODUCTIVE MEDICINE, 2002, 20 (03) : 243 - 248
  • [36] ADRENAL 21-HYDROXYLASE DEFICIENCY IN CHILDHOOD - 25 YEARS EXPERIENCE
    LIM, YJ
    BATCH, JA
    WARNE, GL
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1995, 31 (03) : 222 - 227
  • [37] Decreased cortisol secretion in nonclassical 21-hydroxylase deficiency before and during glucocorticoid therapy
    Weintrob, N
    Israel, S
    Lazar, L
    Lilos, P
    Brautbar, C
    Phillip, M
    Pertzelan, A
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 (07): : 985 - 991
  • [38] 1ST CASE OF NONCLASSICAL 21-HYDROXYLASE DEFICIENCY IN A SEPHARDIC JEWISH WOMAN
    SACERDOTE, A
    CLINICAL RESEARCH, 1990, 38 (03): : A795 - A795
  • [39] NONCLASSICAL 21-HYDROXYLASE DEFICIENCY PRESENTED AS ADDISON'S DISEASE AND BILATERAL ADRENAL INCIDENTALOMAS
    Meng, X.
    Yu, Y.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 232 - 236
  • [40] INSULIN INSENSITIVITY IN ADRENAL-HYPERPLASIA DUE TO NONCLASSICAL STEROID 21-HYDROXYLASE DEFICIENCY
    SPEISER, PW
    SERRAT, J
    NEW, MI
    GERTNER, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06): : 1421 - 1424